Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells

Leuk Res. 2009 Feb;33(2):276-87. doi: 10.1016/j.leukres.2008.06.029. Epub 2008 Aug 8.

Abstract

Sustained ligand stimulation of the receptor tyrosine kinase Flt3 resulted in its downregulation and a refractory signaling phase in primary acute myeloid leukemia (AML) cells and in the AML cell line THP-1. Stable isotope amino acid labeling in cell culture and mass spectrometry were used to compare protein expression patterns in THP-1 before and after Flt3-downregulation. 375 distinct proteins were identified where ATP-dependent RNA helicase DDX3, HNRPU, Matrin-3, Importin-7 and Bax were among the 25 most upregulated proteins and Hausp/UBP7, UBE2N and ERp29 among the 17 most downregulated. THP-1 cells with receptor downregulation were sensitized to idarubicin-induced apoptosis but not cytarabine. We hypothesize that FL-induced receptor modulation may chemosensitize selected AML subsets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis Regulatory Proteins / drug effects*
  • Cell Line, Tumor
  • Cytarabine / pharmacology
  • Down-Regulation / drug effects
  • Drug Synergism
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • Idarubicin / pharmacology*
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / metabolism
  • Leukemia, Myeloid, Acute / pathology
  • Ligands
  • Signal Transduction
  • Up-Regulation
  • fms-Like Tyrosine Kinase 3 / drug effects*
  • fms-Like Tyrosine Kinase 3 / genetics

Substances

  • Apoptosis Regulatory Proteins
  • Ligands
  • Cytarabine
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3
  • Idarubicin